Akoya Biosciences Inc (AKYA)
3.87
+0.07
(+1.84%)
USD |
NASDAQ |
Apr 22, 16:00
3.86
-0.01
(-0.26%)
Pre-Market: 20:00
Akoya Biosciences Debt to Equity Ratio: 1.400 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.400 |
| September 30, 2023 | 1.030 |
| June 30, 2023 | 0.8851 |
| March 31, 2023 | 1.506 |
| December 31, 2022 | 1.080 |
| September 30, 2022 | 0.702 |
| June 30, 2022 | 0.4685 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.3057 |
| December 31, 2021 | 0.2676 |
| September 30, 2021 | 0.2356 |
| June 30, 2021 | 0.2182 |
| March 31, 2021 | -0.5771 |
| December 31, 2020 | -0.6765 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.6765
Minimum
Dec 2020
1.506
Maximum
Mar 2023
0.5265
Average
0.4685
Median
Jun 2022
Debt to Equity Ratio Benchmarks
| Bruker Corp | 0.9305 |
| Azenta Inc | 0.00 |
| Harvard Bioscience Inc | 0.5004 |
| Bionano Genomics Inc | 0.7259 |
| Singular Genomics Systems Inc | 0.0497 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 180.37M |
| Total Liabilities (Quarterly) | 126.60M |
| Shareholders Equity (Quarterly) | 53.77M |
| Current Ratio | 3.446 |
| Net Debt Paydown Yield | -1.88% |